Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» metastatic renal cell carcinoma
metastatic renal cell carcinoma
FDA Approves Avastin Biosimilar for Six Types of Cancer
Pharmacy Times
Wed, 09/28/22 - 10:30 pm
FDA
biosimilars
Vegzelma
Avastin
non-small cell lung cancer
glioblastoma
metastatic colorectal cancer
cervical caner
metastatic renal cell carcinoma
Aveo Oncology's Fotivda receives FDA approval
Pharma Live
Thu, 03/11/21 - 10:32 am
Aveo Oncology
Fotivda
metastatic renal cell carcinoma
FDA
Merck boosts late-phase cancer pipeline with $1.1B Peloton buy
Fierce Biotech
Tue, 05/21/19 - 09:31 am
Merck
M&A
Peloton Therapeutics
metastatic renal cell carcinoma
Clinigen Group Acquires U.S. Rights to Proleukin from Novartis
BioSpace
Wed, 02/13/19 - 10:14 am
Novartis
Clinigen
Proleukin
metastatic renal cell carcinoma
FDA Fast Tracks Calithera Biosciences' CB-839 in Combination with Cabozantinib for Advanced Renal Cell Carcinoma
CP Wire
Wed, 04/18/18 - 07:24 pm
Calithera Biosciences
CB-839
cabozantinib
metastatic renal cell carcinoma